Modern Medicine: Small Companies With Big Ideas

|
Includes: BTEC, CURE, FHLC, FTXH, FXH, HQH, IHE, IYH, JHMH, LNGR, PILL, PJP, PPH, RXD, RXL, RYH, THQ, VHT, XLV, XPH
by: OppenheimerFunds
Summary

It’s not easy to predict health problems but modern technology hopes to improve how we prevent, diagnose, and treat diseases.

A sector once dominated by big pharma is now buzzing about smaller, specialized companies that use technology to deliver personalized treatment. But what does this mean for investors?

We speak with healthcare experts and biomedical pioneers to find out more.

Megatrends Podcast Series

Globalization has made the world we live in very small, and very connected. Market trends are global, companies are innovating faster than ever, and money managers are paying very close attention.

In each episode, author and hedge-fund specialist Maneet Ahuja explores the megatrends that are vastly changing how the world does business. We’ll hear from OppenheimerFunds portfolio managers, and other investors and inventors, about how these trends are creating new strategic opportunities for investors.

Episode 5 - Modern Medicine: Small Companies with Big Ideas

When we talk about new technology, we often forget about the major breakthroughs happening in healthcare. A sector once dominated by big pharma is now buzzing about smaller, specialized companies that use technology to deliver personalized treatment. But what does this mean for investors? We speak with healthcare experts and biomedical pioneers to find out more: Máire Lane, Senior Research Analyst at OppenheimerFunds; Magnus Nillson, CEO of XVIVO Perfusion; Søren Tulstrup, President and CEO of Hansa Medical; and Dr. Tiffany Vora, Research Scientist and entrepreneur.

Mutual funds and exchange traded funds are subject to market risk and volatility. Shares may gain or lose value.

Foreign investments may be volatile and involve additional expenses and special risks, including currency fluctuations, foreign taxes, regulatory and geopolitical risks. Investments in securities of growth companies may be volatile. Emerging and developing market investments may be especially volatile. Eurozone investments may be subject to volatility and liquidity issues. Investing significantly in a particular region, industry, sector or issuer may increase volatility and risk.

The mention of specific companies or sectors does not constitute a recommendation on behalf of any fund or OppenheimerFunds, Inc.

Carefully consider fund investment objectives, risks, charges, and expenses. Visit oppenheimerfunds.com or call your advisor for a prospectus with this and other fund information. Read it carefully before investing.

These views represent the opinions of OppenheimerFunds, Inc. and are not intended as investment advice or to predict or depict the performance of any investment. These views are as of the publication date, and are subject to change based on subsequent developments.

OppenheimerFunds is not affiliated with Seeking Alpha.

© 2019 OppenheimerFunds Distributor, Inc.

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha editors.